Skip to main content

Lactobacillus Model Moiety a New Era Dosage Form as Nutraceuticals and Therapeutic Mediator

  • Chapter
  • First Online:
Biotechnology and Bioforensics

Abstract

In this era Bacteria are mostly considered as pathogenic. Bacteria though are pathogenic but still a few are friendly and essential for human growth and immunity; called as Probiotics. Lactobacillus model moiety is one of such probiotic bacterium which when introduced in sufficient colony serves as new prophylaxis and curing agent. This will increase the innate immunity of humans. Indian market lacks the quality uni-strain product of the probiotics as Nutraceuticals and as Health enhancing drug product. Global market is full of multi-strain microbes dosage form. The best mode to utilize Nutraceutical aspect of probiotics is to convert in dry form. These purified colony; later converted into the solid dry form by spray dry (JISL mini-spray drier) technique. Starch, lactose were used as thermo-protective agent while heat drying technique. Anti-microbial screenings carried out along with In vitro cytotoxicity studies. In vitro cytotoxicity screening evaluated that Lactobacillus powder showings anti-cancer activity nearly same as standard drug with no side effects. Dry powder increased the shelf life of the microbes that resulted in maintenance of viability and activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Bibliography

  1. Vinderola G, Capellini B, Villarreal F, Suaŕez V, Quiberoni A, Reinheimer J (2008) Usefulness of a set of simple in vitro tests for the screening and identification of probiotic candidate strains for dairy use. J Food Sci Technol 41:1678–1688

    CAS  Google Scholar 

  2. Iannitti T, Palmieri B (2010) Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 29:701–725

    Article  CAS  Google Scholar 

  3. Madhwani T, McBain A (2011) Bacteriological effects of a Lactobacillus reuteri probiotic on in vitro oral biofilms. Arch Oral Biol 56:1264–1273

    Article  CAS  Google Scholar 

  4. Preidis G, Versalovic J (2009) Targeting the human microbiome with antibiotics probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015–2031

    Article  CAS  Google Scholar 

  5. Kaur I, Chopra K, Saini A (2002) Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15:1–9

    Article  CAS  Google Scholar 

  6. Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27(3):202–209

    Article  CAS  Google Scholar 

  7. Bernstein C et al (2009) Inflammatory bowel disease: a global perspective. World Gastroenterology Organisation Global Guidelines, USA, pp 1–24

    Google Scholar 

  8. Macfarlane S, Furrie E, Kennedy A, Cummings J, Macfarlane G (2005) Mucosal bacteria in ulcerative colitis. Br J Nutr 93:67–72

    Article  Google Scholar 

  9. Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Poussa T, Mykkänen H, Korpela R (2008) The influence of lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128:406–410

    Article  CAS  Google Scholar 

  10. Roller M, Clune Y, Collins K, Rechkemzer G, Watzl B (2007) Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97:676–684

    Article  CAS  Google Scholar 

  11. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson C, Klinder A, O’Riordan M, O’Sullivan C, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs H, Van Loo J, Watzl B, Collins K (2007) Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85:488–496

    CAS  Google Scholar 

  12. Liong M (2008) Safety of probiotics: translocation and infection. Nutr Rev 66(4):192–202

    Article  Google Scholar 

  13. Lewandowicz G, Harding B, Harkness W, Hayward R, Thomas DG, Darling L (2000) Chemosensitivity in childhood brain tumours in vitro: evidence of differential sensitivity to lomustine (CCNU) and vincristine. Cancer 36:1955–1964

    Google Scholar 

  14. Tanaka T (2009) Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinog 8:1–19

    Article  CAS  Google Scholar 

  15. Tortora G, Grabowski S (2003) Principles of anatomy and physiology, 10th edn. Wiley, New Jersey, pp 853–855, pp 891–893

    Google Scholar 

  16. Levi E, Misra S, Du J, Patel B, Majumdar P (2009) Combination of aging and dimethylhydrazine treatment causes an increase in cancer—stem cell population of rat colonic crypts. Biochem Biophys Res Commun 385:430–433

    Article  CAS  Google Scholar 

  17. Ahmad S, Anjum F, Huma N, Sameen A, Zahoor T (2013) Composition and physico-chemical characteristics of buffalo milk with particular emphasis on lipids, proteins, minerals, enzymes and vitamins. J Anim Plant Sci 23:62–74

    CAS  Google Scholar 

  18. Shah NP, Ravula RR (2002) Microencapsulation of probiotic bacteria and their survival in frozen fermented dairy desserts. Aust J Dairy Technol 55(3):139–144

    Article  Google Scholar 

  19. Adhikari K, Mustapha A, Grun IU (2003) Survival and metabolic activity of microencapsulated Bifidobacterium longum in stirred yoghurt. J Food Sci 68(1):275–280

    Article  CAS  Google Scholar 

  20. Albertini B, Passerini N, Pattarino F, Rodriguez L (2008) New spray-congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances. Eur J Pharm Biopharm Sci 69:348–357

    Article  CAS  Google Scholar 

  21. Albertini B, Passerini N, Di-Sabatino M, Vitali B, Brigidi P, Rodriguez L (2009) Polymer–lipid based mucoadhesive microspheres prepared by spray congealing for the vaginal delivery of Econazole nitrate. Eur J Pharm Sci 36:591–601

    Article  CAS  Google Scholar 

  22. Albertini B, Vitali B, Passerini N, Cruciani F, Di-Sabatino M, Rodriguez L, Brigidi P (2010) Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidbacterium lactis. Eur J Pharm Sci 40:359–366

    Article  CAS  Google Scholar 

  23. Rault A, Bouix M, Béal C (2010) Cryotolerance of Lactobacillus delbrueckii subsp. bulgaricus CFL1 is influenced by the physiological state during fermentation. Int Dairy J 20:792–799

    Article  CAS  Google Scholar 

  24. Wargovich MJ et al (2000) Efficacy of potential chemopreventive agent on rat colon aberrant crypt formation and progression. Carcinogenesis 21(6):1149–1155

    Article  CAS  Google Scholar 

  25. Fasoli S et al (2003) Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 82:59–70

    Article  CAS  Google Scholar 

  26. Ananta E et al (2005) Cellular injuries and storage stability of spray-dried Lactobacillus rhamnosus GG. Int Dairy J 15:399–409

    Article  CAS  Google Scholar 

  27. Semyonov D et al (2010) Microencapsulation of Lactobacillus paracasei by spray freeze drying. J Food Res Int 43:193–202

    Article  CAS  Google Scholar 

  28. Albertini B et al (2010) Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis. Eur J Pharm Sci 40:359–366

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abhinandan R. Patil .

Rights and permissions

Reprints and permissions

Copyright information

© 2015 The Author(s)

About this chapter

Cite this chapter

Patil, A.R., Shinde, S.S., Kakade, P.S., D’souza, J.I. (2015). Lactobacillus Model Moiety a New Era Dosage Form as Nutraceuticals and Therapeutic Mediator. In: Biotechnology and Bioforensics. SpringerBriefs in Applied Sciences and Technology(). Springer, Singapore. https://doi.org/10.1007/978-981-287-050-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-050-6_2

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-049-0

  • Online ISBN: 978-981-287-050-6

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics